1. Beck M. Mucopolysaccharides and Oligosaccharides. In: Fernandes J, Saudubray.M, van den Berghe G (eds), Inborn Metabolic Diseases, Diagnosis and Treatment. Springer Verlag ISBN 3–540–65626. Third edition, 2001.
2. Steward CG. Bone marrow transplantation for genetic diseases. In: Fairbarn LJ, Testa NG (eds) Blood cell Biochemistry. Volume 8: Haemopoiesis and Gene Therapy. New York: Kluwer Academic/Plenum Publishers. 13–56.
3. Wraith JE. Advances in the treatment of lysosomal storage disease. Dev Med Child Neurol 2001; 43: 639–46.
4. Poorthuis BJ, Wevers RA, KLeijer WJ, et al. The frequency of lysosomal storage disease in The Netherlands. Human Genetics 1999; 105: 151–56.
5. Koç ON, Peters Ch, Augbourg P, et al.. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogenic transplantation in patients with lysosomal and peroxysomal storage diseases. Exp Hematol 1999; 27: 1675–81.